Posted in Antibodies, Assay Kits, Biology Cells, Clia Kits, Culture Cells, Devices, DNA, DNA Templates, Elisa Kits, Enzymes, Equipments, Exosomes, NATtrol, Panel, PCR, Pcr Kits, Peptides

Improvement of in situ Follicular Activation and Early Development in Cryopreserved Human Ovarian Cortical Tissue by Co-Culturing with Mesenchymal Stem Cells.

Improvement of in situ Follicular Activation and Early Development in Cryopreserved Human Ovarian Cortical Tissue by Co-Culturing with Mesenchymal Stem Cells.

Follicle losses and network degeneration are major challenges in the ovarian tissue culture system. Mesenchymal (MSC) stem cells emit the cocktail of growth and cytokines that support adjacent cells and networks. The purpose of this study was to investigate the impact of the human bone marrow (HBM) -MSC, as culture cells, in the development of follicular humans in ovarian cortical tissue (October). For this purpose, the OCT fraction was properly cultured along with HBM-MSC for 8 days and compared to October monoculture. During the cultural period, survival and development of ovarians in October was evaluated using histological observation, gene expression associated with follicular development, and estradiol production.

Furthermore, cell proliferation and apoptosis are assessed. The results showed that there was no significant difference in ovarian follicles which were preserved with normal morphology between the two groups. However, the percentage of follicular development, as well as the expression of follicular development gene, increased significantly in cultural groups compared to monoculture groups. On the other hand, compared to the monoculture group, the culture group showed a significant increase in cell proliferation, indicated by the expression of KI67 gene, and a dramatic decline in the percentage of apoptotic cells, revealed by the Tunel test. These findings indicate that the HBM-MSC co-cultivation with October can increase the activation of follicles and the development of initial follicles in the human ovarian network culture system.

The increase in the efficacy of Vivo from the clinical class of cryopreserved human hepatocytes in mice with acute liver failure.

Clinical clinical hepatocytes of short-term efficacy has been shown; However, some of the main limitations, mainly due to lack of organs, the lack of quality of insulated cells and low cells after transplantation, must be resolved to increase its efficacy in clinical applications. Cellular stress during isolation causes loss of unexpected cell attachment capabilities, which can be exacerbated by cryopreservation and disbursement. In this work, we focus on the use of good manufacturing practices (GMP) solutions compared to standard cryopreservation media, Wisconsin University media, for the purpose of improving the functional quality of cells and its ability to instill in vivo, with the idea of ​​establishing biobank from human hepatocytes Cryopreserved available for use their clinical.

We evaluate not only cell viability but also certain liver function indicators of functional performance of cells such as attachment efficiency, urogenic capabilities, phase and II enzyme enzyme activities and specific adhesion molecular expressions in vitro. In addition, we also assess and compare the efficacy of in vivo from hepatocytes of human hepatocytes in different media in the animal model of acute liver failure. Humatocytes of Cryopreserved Humans in GMP solutions new offers in vitro functionality better and in vivo compared to those who are cryopreserved in standard media. Overall, the results showed that the GMP solution tested newly maintained better liver function and, most importantly, showed better results in Vivo, which could imply an increase in the long-term efficacy when used in patients.

The genetic diagnosis of β-thalassemia preplantation uses short tandem repetition on cryopreserved human blastocythis.

This study aims to evaluate the application of short tandem repetitions (STRS) for the diagnosis of genetic prequlantation (PGD) β-thalassemia. This is a prospective study that appears at the Pregnant Hospital and Liuzhou Child Health. From May to December 2016, eight couples formed from two β-thalassemia operators underwent a procedure and PGD fertilization (IVF) in vitro. All couples and four family members / couples undergo blood testing. Genome amplification of all trophy cell cells is done. PCR products are used for link analysis of 15 strokus. Of the eight couples, 147 embryos were obtained and 86 blastokistas were formed. DNA from 82 Blastokista was successfully reinforced (95.4% amplification efficiency).

Improvement of in situ Follicular Activation and Early Development in Cryopreserved Human Ovarian Cortical Tissue by Co-Culturing with Mesenchymal Stem Cells.

Eighty Blastokista obtained a definite diagnosis. Among them, 24 blastokistas were diagnosed as normal, 38 blastokistas were diagnosed as heterozygous for β-thalassemia, and 18 homozygous blastokistas or heterozygous compounds. Two patients received a melting embryo and both had clinical pregnancies. These results indicate that in the PGD settings for β-thalassemia, after several displacement amplifications, the reverse dot hybridization combined with strs can be an effective, accurate, and practical clinical strategy to increase β-thalassemia detection in pairs that are at risk of transferring embryo. These results must be validated in a larger cohort.

Is the 7th day of the 7th culture for fertilizing in vitro from the oocyte of cryopreserved / warm man?

Human embryos are usually cultured to the Blastokyst stage on day 5 or 6 after insemination. However, some embryos grew slowly and reached the Blastokyst stage on Day 7. The level of direct birth. Acceptable birthday has been reported after the 7-blastocista day transfer is produced from the fresh oockey in vitro fertilization (IVF). It is not known whether an extended embryonic culture until the 7th day is needed for more ivf ocyte ivf to get a more transfer blastocist. In this study, 455 oocytes of 57 cycles were warmed, inseminated, and the resulting embryo was cultured by day 7 to test the development after the expanded culture.

Human Peripheral Blood CD3+ T Cells, Cryopreserved
PBCD3-C20M - Ask for price

Human Cord Blood CD34+ Cells, Cryopreserved, single donor
CBCD34-C0.5M - Ask for price

Human Cord Blood CD34+ Cells, Cryopreserved, mixed donor 
CBCD34mix-C0.5M - Ask for price

Human Cord Blood CD34+ Cells, Cryopreserved, mixed donor 
CBCD34mix-C1M - Ask for price

Human Cord Blood CD34+ Cells, Cryopreserved, mixed donor 
CBCD34mix-C5M - Ask for price

Human Cord Blood CD34+ Cells, Cryopreserved, single donor 
CBCD34-C1M - Ask for price

Human Normal Peripheral Blood Mononuclear Cells (PBMC), Cryopreserved
PBMC-C100M - Ask for price

Human Normal Peripheral Blood Mononuclear Cells (PBMC), Cryopreserved
PBMC-C10M - Ask for price

Human Normal Peripheral Blood Mononuclear Cells (PBMC), Cryopreserved
PBMC-C20M - Ask for price

Human Normal Peripheral Blood Mononuclear Cells (PBMC), Cryopreserved
PBMC-C50M - Ask for price

Human  Peripheral  Blood  CD4+  T  Lymphocytes, Cryopreserved
PBCD4-C10M - Ask for price

Human  Peripheral  Blood  CD14+ Monocytes, Cryopreserved / Untouched
PBCD14U-C10M - Ask for price

Human Normal Peripheral Blood CD4+/CD25+ Regulatory T Cells (T reg), Cryopreserved
PBCD4-25-C2M - Ask for price

Human  Peripheral  Blood  CD14+ Monocytes, Cryopreserved / Positive selection
PBCD14P-C10M - Ask for price

Positively Selected Normal Peripheral Blood CD19+ B Cells, Cryopreserved
PBCD19P-C10M - Ask for price

Endothelial Cryopreserve Media
FM300 10 ml
EUR 308.4

CRYOPRESERVATION BAG, 50ML
91-200-88 1/pk
EUR 97.2
Description: Flexible Containers; Bioprocess Bags and Parts

CRYOPRESERVATION BAG, 250ML
91-200-89 1/pk
EUR 100.8
Description: Flexible Containers; Bioprocess Bags and Parts

CRYOPRESERVATION BAG, 500ML
91-200-90 1/pk
EUR 104.4
Description: Flexible Containers; Bioprocess Bags and Parts

CRYOPRESERVATION BAG, 750ML
91-200-91 1/pk
EUR 108
Description: Flexible Containers; Bioprocess Bags and Parts

Cryopreservation Medium For Human Embryonic Stem Cells
HUXES-07031 20/50mL Ask for price

AddexBio Cryopreservation Medium
C0002-20mL RT vial
EUR 124.8

Cryopreservation Medium For General Use
CYRO-10001 20/50mL Ask for price

NCR Cryopreservation Medium For General Use
NCRC-10001 20/50mL Ask for price

Cryopreservation Medium For Neural Stem Cells
GUXNX-07031 20/50mL Ask for price

NCR Protein-Free Cryopreservation Medium For General Use
NCPF-10001 20/50mL Ask for price

Chemical Defined Xeno-free Cell Cryopreservation Medium
abx298009-20ml 20 ml
EUR 292.8

NCR Protein-Free Cryopreservation Medium For Neural Stem Cells
GUXNX-07021 20/50mL Ask for price

COOLCELL SV2 STEMCELL CRYOPRESERVATION SYSTEM INCLUDES THE XT STARTER BENCHTOP COOLER, COOLRACK SV2 AND COOLCELL SV2 CELL FREEZING CONTAINER FOR 12 INJECTABLE VIALS
432012 1/pk
EUR 1024.8
Description: BioCision; BioCision CoolCell

COOLCELL SV10 STEMCELL CRYOPRESERVATION SYSTEM INCLUDES THE XT STARTER BENCHTOP COOLER, COOLRACK SV10 AND COOLCELL SV10 CELL FREEZING CONTAINER FOR 6 INJECTABLE VIALS
432013 1/pk
EUR 1024.8
Description: BioCision; BioCision CoolCell

Total RNA - Human Tumor Tissue: Synoviosarcoma
R1235257-10 10 ug
EUR 400

Total Protein - Human Tumor Tissue: Synoviosarcoma
P1235257 1 mg
EUR 471

Human E3 ubiquitin- protein ligase synoviolin, SYVN1 ELISA KIT
ELI-29339h 96 Tests
EUR 988.8

Human E3 ubiquitin-protein ligase synoviolin (SYVN1) ELISA Kit
abx383609-96tests 96 tests
EUR 1093.2

ELISA kit for Human E3 ubiquitin-protein ligase synoviolin (SYVN1)
KTE60446-48T 48T
EUR 398.4
Description: Quantitative sandwich ELISA for measuring Human E3 ubiquitin-protein ligase synoviolin (SYVN1) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Human E3 ubiquitin-protein ligase synoviolin (SYVN1)
KTE60446-5platesof96wells 5 plates of 96 wells
EUR 2538
Description: Quantitative sandwich ELISA for measuring Human E3 ubiquitin-protein ligase synoviolin (SYVN1) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Human E3 ubiquitin-protein ligase synoviolin (SYVN1)
KTE60446-96T 96T
EUR 646.8
Description: Quantitative sandwich ELISA for measuring Human E3 ubiquitin-protein ligase synoviolin (SYVN1) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

Synovial Apoptosis Inhibitor 1, Synoviolin Antibody
20-abx115960
  • EUR 878.40
  • EUR 477.60
  • 150 ul
  • 50 ul

E3 Ubiquitin-Protein Ligase Synoviolin (HRD1) Antibody
abx031572-400ul 400 ul
EUR 627.6

E3 Ubiquitin-Protein Ligase Synoviolin (HRD1) Antibody
abx031572-80l 80 µl
EUR 343.2

Mouse E3 ubiquitin- protein ligase synoviolin, Syvn1 ELISA KIT
ELI-23703m 96 Tests
EUR 1038

E3 Ubiquitin-Protein Ligase Synoviolin (SYVN1) Antibody
abx238463-100ug 100 ug
EUR 610.8

E3 ubiquitin-protein ligase synoviolin (SYVN1) Antibody
20-abx211798
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

E3 Ubiquitin-Protein Ligase Synoviolin (SYVN1) Antibody
abx025097-400ul 400 ul
EUR 627.6

E3 Ubiquitin-Protein Ligase Synoviolin (SYVN1) Antibody
abx025097-80l 80 µl
EUR 343.2

E3 Ubiquitin-Protein Ligase Synoviolin (SYVN1) Antibody
abx025098-400ul 400 ul
EUR 627.6

E3 Ubiquitin-Protein Ligase Synoviolin (SYVN1) Antibody
abx025098-80l 80 µl
EUR 343.2

E3 Ubiquitin-Protein Ligase Synoviolin (SYVN1) Antibody
abx431931-200ul 200 ul
EUR 460.8

E3 Ubiquitin-Protein Ligase Synoviolin (SYVN1) Antibody
abx431932-200ul 200 ul
EUR 460.8

E3 Ubiquitin-Protein Ligase Synoviolin (SYVN1) Antibody
20-abx002034
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

E3 Ubiquitin-Protein Ligase Synoviolin (SYVN1) Antibody
20-abx302155
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

E3 Ubiquitin-Protein Ligase Synoviolin (SYVN1) Antibody (HRP)
20-abx314566
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Mouse E3 ubiquitin-protein ligase synoviolin (SYVN1) ELISA Kit
abx390695-96tests 96 tests
EUR 1093.2

Syvn1 ELISA Kit| Mouse E3 ubiquitin-protein ligase synoviolin E
EF016338 96 Tests
EUR 826.8

E3 Ubiquitin-Protein Ligase Synoviolin (SYVN1) Antibody (FITC)
20-abx314567
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

ELISA kit for Mouse E3 ubiquitin-protein ligase synoviolin (SYVN1)
KTE70316-48T 48T
EUR 398.4
Description: Quantitative sandwich ELISA for measuring Mouse E3 ubiquitin-protein ligase synoviolin (SYVN1) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Mouse E3 ubiquitin-protein ligase synoviolin (SYVN1)
KTE70316-5platesof96wells 5 plates of 96 wells
EUR 2538
Description: Quantitative sandwich ELISA for measuring Mouse E3 ubiquitin-protein ligase synoviolin (SYVN1) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Mouse E3 ubiquitin-protein ligase synoviolin (SYVN1)
KTE70316-96T 96T
EUR 646.8
Description: Quantitative sandwich ELISA for measuring Mouse E3 ubiquitin-protein ligase synoviolin (SYVN1) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

E3 Ubiquitin-Protein Ligase Synoviolin (SYVN1) Antibody (Biotin)
20-abx314568
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Nori® Human IL-12 ELISA Kit- Synovial Fluid
GR106141-SF 96-well
EUR 461

CryoProtX
M-MD1-61 46 x 1.5 ml ml
EUR 360
Description: CryoProtX

Nori® Human VEGF ELISA Kit- Synovial Fluid-2 Plates
GR111005-SF-2 2 x 96-well
EUR 832

Human Bone Joint PrimaCell: Normal Synovial Cell
2-96011 1 Kit Ask for price

Nori® Human IL-13 ELISA Kit- Synovial Fluid-2 Plates
GR111006-SF-2 2 x 96-well
EUR 832

CryoProtX Eco Screen
M-MD1-61-ECO 46 x 1.5 ml ml
EUR 360
Description: CryoProtX Eco Screen

Human Synovial Microvascular Endothelial Cells
HEC10 500,000+ Cells
EUR 1296

CryoProtX Mix Reagents 1.5 mL
M-MDSR-61 1.5 ml ml
EUR 37
Description: CryoProtX Mix Reagents 1.5 mL

CryoProtX Mix Eco Reagents 1.5 mL
M-MDSR-61-ECO 1.5 ml ml
EUR 37
Description: CryoProtX Mix Eco Reagents 1.5 mL

Paraffin Tissue Section - Human Bone Tumor: Synovial Sarcoma
T2235023-8 5 slides
EUR 238

Human Bone Joint PrimaCell: Normal Synovial Cells Growth Medium
9-46011 5 x 100 ml Ask for price

Human Bone Joint Tissue Preparation Buffer: Normal Synovial Cells
9-80011 1 x 100 ml Ask for price

SSX1 Synovial Sarcoma, X Breakpoint 1 Human Recombinant Protein
PROTQ16384 Regular: 10ug
EUR 380.4
Description: SSX1 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 211 amino acids (1-188 a.a) and having a molecular mass of 24.3kDa.;SSX1 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

SSX2 Synovial Sarcoma, X Breakpoint 2 Human Recombinant Protein
PROTQ16385 Regular: 10ug
EUR 380.4
Description: SSX2 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 210 amino acids (1-188a.a) and having a molecular mass of 24.0kDa. ;SSX2 is fused to a 22 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

FD Tissue Cryoprotection Solution™
PC102 250 ml
EUR 156

20 x Synovial Fluid Solution
GR103059 100 mL
EUR 70

Mycoplasma synoviae PCR kit
PCR-M405-48D 50T
EUR 543.6

Mycoplasma synoviae PCR kit
PCR-M405-96D 100T
EUR 686.4

Mycoplasma synoviae RT PCR kit
RTq-M405-100D 100T
EUR 860.4

Mycoplasma synoviae RT PCR kit
RTq-M405-150D 150T
EUR 969.6

Mycoplasma synoviae RT PCR kit
RTq-M405-50D 50T
EUR 717.6

Human Bone Joint PrimaCell: Normal Synovial Cells Growth Supplements with Serum (for 500 ml medium)
9-47011 1 Set Ask for price

Synovial sarcoma tissue array
SS1001 each
EUR 348
Description: Synovial sarcoma tissue array, including TNM, clinical stage and pathology grade, 50 cases/100 cores

Mycoplasma synoviae One-Step PCR kit
Oneq-M405-100D 100T
EUR 1039.2

Mycoplasma synoviae One-Step PCR kit
Oneq-M405-150D 150T
EUR 1177.2

Mycoplasma synoviae One-Step PCR kit
Oneq-M405-50D 50T
EUR 861.6

Nori® Canine (dog) IL-6 ELISA Kit- Synovial Fluid
GR106143-SF 96-well
EUR 461

Nori® Canine (dog) IL-12 ELISA Kit- Synovial Fluid
GR106142-SF 96-well
EUR 461

Nori® Rat VEGF ELISA Kit- Synovial Fluid-2 Plates
GR-118002-SF-2 2 x 96-well
EUR 832

Synovial Sarcoma, X Breakpoint 1 Protein
20-abx262587
  • EUR 393.60
  • EUR 7676.40
  • EUR 276.00
  • 10 ug
  • 1 mg
  • 2 µg

Nori® Equine (horse) TLR3 ELISA Kit- Synovial Fluid
GR106098-SF 96-well
EUR 461

Nori® Equine (horse) IL-12 ELISA Kit- Synovial Fluid
GR106140-SF 96-well
EUR 461

TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody
BNC942051-100 100uL
EUR 279.6
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF594 conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody
BNC942051-500 500uL
EUR 654
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF594 conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody
BNC942062-100 100uL
EUR 279.6
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF594 conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody
BNC942062-500 500uL
EUR 654
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF594 conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody
BNC942085-100 100uL
EUR 279.6
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF594 conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody
BNC942085-500 500uL
EUR 654
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF594 conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody
BNC802051-100 100uL
EUR 279.6
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF680 conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody
BNC802051-500 500uL
EUR 654
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF680 conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody
BNC802062-100 100uL
EUR 279.6
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF680 conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody
BNC802062-500 500uL
EUR 654
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF680 conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody
BNC802085-100 100uL
EUR 279.6
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF680 conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody
BNC802085-500 500uL
EUR 654
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF680 conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody
BNC702051-100 100uL
EUR 279.6
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF770 conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody
BNC702051-500 500uL
EUR 654
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF770 conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody
BNC702062-100 100uL
EUR 279.6
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF770 conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody
BNC702062-500 500uL
EUR 654
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF770 conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody
BNC702085-100 100uL
EUR 279.6
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF770 conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody
BNC702085-500 500uL
EUR 654
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF770 conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody
BNC882051-100 100uL
EUR 279.6
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF488A conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody
BNC882051-500 500uL
EUR 654
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF488A conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody
BNC882062-100 100uL
EUR 279.6
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF488A conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody
BNC882062-500 500uL
EUR 654
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF488A conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody
BNC882085-100 100uL
EUR 279.6
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF488A conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody
BNC882085-500 500uL
EUR 654
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF488A conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody
BNC812051-100 100uL
EUR 279.6
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF680R conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody
BNC812051-500 500uL
EUR 654
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF680R conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody
BNC812062-100 100uL
EUR 279.6
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF680R conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody
BNC812062-500 500uL
EUR 654
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF680R conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody
BNC812085-100 100uL
EUR 279.6
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF680R conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody
BNC812085-500 500uL
EUR 654
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF680R conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody
BNC052051-100 100uL
EUR 279.6
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF405M conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody
BNC052051-500 500uL
EUR 654
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF405M conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody
BNC052062-100 100uL
EUR 279.6
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF405M conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody
BNC052062-500 500uL
EUR 654
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF405M conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody
BNC052085-100 100uL
EUR 279.6
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF405M conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody
BNC052085-500 500uL
EUR 654
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF405M conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody
BNC042051-100 100uL
EUR 279.6
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF405S conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody
BNC042051-500 500uL
EUR 654
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF405S conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody
BNC042062-100 100uL
EUR 279.6
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF405S conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody
BNC042062-500 500uL
EUR 654
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF405S conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody
BNC042085-100 100uL
EUR 279.6
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF405S conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody
BNC042085-500 500uL
EUR 654
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF405S conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody
BNC402051-100 100uL
EUR 279.6
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF640R conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody
BNC402051-500 500uL
EUR 654
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF640R conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody
BNC402062-100 100uL
EUR 279.6
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF640R conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody
BNC402062-500 500uL
EUR 654
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF640R conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody
BNC402085-100 100uL
EUR 279.6
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF640R conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody
BNC402085-500 500uL
EUR 654
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF640R conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody
BNCAP2051-100 100uL
EUR 279.6
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody
BNCAP2051-500 500uL
EUR 654
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody
BNCAP2062-100 100uL
EUR 279.6
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody
BNCAP2062-500 500uL
EUR 654
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody
BNCAP2085-100 100uL
EUR 279.6
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody
BNCAP2085-500 500uL
EUR 654
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody
BNCA2051-250 250uL
EUR 472.8
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), APC conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody
BNCA2062-250 250uL
EUR 472.8
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), APC conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody
BNCA2085-250 250uL
EUR 472.8
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), APC conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody
BNCP2051-250 250uL
EUR 472.8
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), PerCP conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody
BNCP2062-250 250uL
EUR 472.8
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), PerCP conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody
BNCP2085-250 250uL
EUR 472.8
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), PerCP conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody
BNCR2051-250 250uL
EUR 472.8
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), RPE conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody
BNCR2062-250 250uL
EUR 472.8
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), RPE conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody
BNCR2085-250 250uL
EUR 472.8
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), RPE conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody
BNCH2051-100 100uL
EUR 279.6
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody
BNCH2051-500 500uL
EUR 654
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody
BNCH2062-100 100uL
EUR 279.6
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody
BNCH2062-500 500uL
EUR 654
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody
BNCH2085-100 100uL
EUR 279.6
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody
BNCH2085-500 500uL
EUR 654
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody
BNCB2051-100 100uL
EUR 279.6
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), Biotin conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody
BNCB2051-500 500uL
EUR 654
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), Biotin conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody
BNCB2062-100 100uL
EUR 279.6
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), Biotin conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody
BNCB2062-500 500uL
EUR 654
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), Biotin conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody
BNCB2085-100 100uL
EUR 279.6
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), Biotin conjugate, Concentration: 0.1mg/mL

TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody
BNCB2085-500 500uL
EUR 654
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), Biotin conjugate, Concentration: 0.1mg/mL

Fifty-one blastokista of the 16 cycles of being used to examine the embryo Aneuploidies Day 7 Blastokista accounted for 15.6% of the total blastokist. The proportion of the top quality of the blastokist is lower on the 7th day than on day 5 or 6. However, there is no difference observed at the level of blastokyst aneuploid between days 5, 6 and 7. Similar clinical pregnancies, ongoing pregnancy and embryonic implantation rates Obtained after the 7th day of the Blastocyst transfer compared to day 5 or 6 blastocyst transfers. These results indicate that the embryo of the oocyte heating cycle must be cultured until 7 days if they do not reach the Blastokyst stage on the 6th day so that the number of blastokistas that can be used can be increased.

Shelby

Leave A Comment